跳至主要内容
临床试验/IRCT2016041118745N4
IRCT2016041118745N4已完成1 期

Pharmacokinetic evaluation of Paclynap formulation in comparison with Abraxan in pancreatic cancer patients

ano Daru Pajuhan Pardis Co0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • inclusion criteria: with written consent; patients with Local Advanced Pancreatic Cancer.
  • exclusion criteria: patients with hepatic and renal disorders; patients with acute and chronic heart disease; patients with pulmonary and cerebral metastasis; patient with decreased albumin levels of two times of normal; patients with enhanced blood bilirubin of 3 times over.

排除标准

  • 未提供

研究者

发起方
ano Daru Pajuhan Pardis Co

相似试验

已完成
不适用
Pharmacokinetic and Pharmacodynamic study of nab-Paclitaxel and solvent-based Paclitaxel in patients with metastatic or recurrent gastric cancerMetastatic or recurrent gastric cancer
JPRN-UMIN000030277Shizuoka Cancer Center24
进行中(未招募)
不适用
Pharmacokinetic evaluation of a new formulation of recombinant factor IX (BeneFIX) in the italian population with severe or moderate B haemophilia previously treated. - NDPatients with severe or moderate B Haemophilia, previously treated with rFIX.MedDRA version: 9.1Level: SOCClassification code 10010331
EUCTR2008-006465-85-ITAZIENDA OSPEDALIERA UNIVERSITARIA CAREGGI
已完成
1 期
Evaluation of the Pharmacokinetics of IPX233 Formulations in Healthy VolunteersAttention Deficit Hyperactivity Disorder (ADHD)Neurological - Other neurological disorders
ACTRN12613001073796Impax Pharmaceuticals,A Division of Impax Laboratories, Inc.20
进行中(未招募)
不适用
Evaluation of pharmacokinetic and pharmacodynamic interactions between escitalopram and drugs used for the treatment of bipolar disorders. - NDbipolar disordersMedDRA version: 9.1Level: LLTClassification code 10057667Term: Bipolar disorder
EUCTR2008-000370-20-ITAZIENDA OSPEDALIERA PISANA
尚未招募
4 期
A pharmacokinetic evaluation of the addition of Aprepitant to the Cisplatin - Etoposide (CE) treatment of patients with metastatic lung carcinoma (ACE)misselijkheid en braken na toedienen cytostatica kuurnausea and vomiting10027656
NL-OMON31383niversitair Medisch Centrum Sint Radboud20
Evaluation of blood levels of Paclynap produced drug... | 临床试验